Table 3.
LV Function at Baseline and After 1 Year of Follow-Up in CS Patients Who Underwent Corticosteroid Therapy
| Initial LV Function | Baseline (%) | 1-Year Follow-Up Period (%) | P Value |
|---|---|---|---|
| All CS | |||
| Normal (LVEF ≥50%), n = 106 | 60.9 ± 6.8 | 59.7 ± 12.5 | 0.865 |
| Moderate (50% > LVEF >35%), n = 63 | 43.0 ± 3.9 | 41.2 ± 10.4 | 0.910 |
| Low (LVEF ≤35%), n = 48 | 25.3 ± 6.5 | 32.0 ± 10.0 | <0.001 |
| Histological CS | |||
| Normal (LVEF ≥50%), n = 9 | 60.9 ± 6.7 | 51.7 ± 18.8 | 0.929 |
| Moderate (50% > LVEF >35%), n = 11 | 41.6 ± 4.1 | 33.7 ± 9.1 | 0.983 |
| Low (LVEF ≤35%), n = 19 | 24.1 ± 7.0 | 31.2 ± 11.1 | 0.001 |
| Clinical CS | |||
| Normal (LVEF ≥50%), n = 97 | 60.9 ± 6.9 | 60.4 ± 11.6 | 0.677 |
| Moderate (50% > LVEF >35%), n = 52 | 43.3 ± 3.8 | 42.8 ± 10.0 | 0.649 |
| Low (LVEF ≤35%), n = 29 | 26.1 ± 6.1 | 32.4 ± 9.3 | <0.001 |
Values are mean ± SD.
LV = left ventricle; other abbreviations as in Table 2.